ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,186 | +7.9% | 296 | 0.0% | 0.00% | – |
| Q2 2023 | $15,934 | +132683.3% | 296 | +2.1% | 0.00% | – |
| Q1 2023 | $12 | 0.0% | 290 | 0.0% | 0.00% | – |
| Q4 2022 | $12 | -99.9% | 290 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | +22.2% | 290 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | +12.5% | 290 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -86.9% | 290 | -80.8% | 0.00% | – |
| Q4 2021 | $61,000 | -3.2% | 1,510 | -20.9% | 0.00% | – |
| Q3 2021 | $63,000 | -10.0% | 1,910 | -5.0% | 0.00% | – |
| Q2 2021 | $70,000 | +366.7% | 2,010 | +390.2% | 0.00% | – |
| Q1 2021 | $15,000 | +25.0% | 410 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | +300.0% | 410 | +272.7% | 0.00% | – |
| Q3 2020 | $3,000 | -25.0% | 110 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | -98.6% | 110 | -98.4% | 0.00% | -100.0% |
| Q1 2020 | $277,000 | -33.9% | 6,790 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $419,000 | +84.6% | 6,790 | +117.6% | 0.00% | +100.0% |
| Q3 2019 | $227,000 | -63.6% | 3,120 | -58.9% | 0.00% | -66.7% |
| Q2 2019 | $624,000 | +16.6% | 7,588 | 0.0% | 0.01% | +20.0% |
| Q1 2019 | $535,000 | +10600.0% | 7,588 | +6798.2% | 0.01% | – |
| Q4 2018 | $5,000 | -16.7% | 110 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | -14.3% | 110 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | -96.4% | 110 | -96.3% | 0.00% | -100.0% |
| Q1 2018 | $192,000 | -4.0% | 3,010 | -3.2% | 0.00% | 0.0% |
| Q4 2017 | $200,000 | +22.7% | 3,110 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $163,000 | +19.9% | 3,110 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $136,000 | -11.7% | 3,110 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $154,000 | -59.0% | 3,110 | -49.8% | 0.00% | -60.0% |
| Q4 2016 | $376,000 | +77.4% | 6,200 | +93.8% | 0.01% | +66.7% |
| Q3 2016 | $212,000 | +18.4% | 3,200 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $179,000 | +65.7% | 3,200 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $108,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |